Laidlaw Wealth Management LLC Moderna, Inc. Transaction History

Laidlaw Wealth Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $36,697 - $65,112	-310 Reduced 16.82%	1,533 $275,000
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $23,614 - $38,836	200 Added 12.17%	1,843 $218,000
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $14,289 - $21,543	-122 Reduced 6.91%	1,643 $235,000
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $132,783 - $246,802	-1,050 Reduced 37.3%	1,765 $304,000
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $124,426 - $203,049	551 Added 24.34%	2,815 $715,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $25,074 - $54,745	113 Added 5.25%	2,264 $871,000
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $67,553 - $122,189	-520 Reduced 19.47%	2,151 $505,000
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $26,858 - $45,751	246 Added 10.14%	2,671 $350,000
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $159,419 - $411,910	2,425 New	2,425 $253,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Laidlaw Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Laidlaw Wealth Management LLC with notifications on news.